Jiangsu Nhwa Pharmaceutical Management

Management Kriterienprüfungen 3/4

Jiangsu Nhwa Pharmaceutical's CEO ist Jiaquan Sun , ernannt in May 2013, hat eine Amtszeit von 11.08 Jahren. besitzt direkt 0.071% der Aktien des Unternehmens, im Wert von CN¥17.15M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 11.1 Jahre bzw. 17.2 Jahre.

Wichtige Informationen

Jiaquan Sun

Geschäftsführender

CN¥4.8m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	11.3yrs
Eigentum des Geschäftsführers	0.07%
Durchschnittliche Amtszeit des Managements	11.3yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	17.4yrs

Jüngste Management Updates

Recent updates

Geschäftsführer

Jiaquan Sun (48 yo)

11.3yrs

Amtszeit

CN¥4,800,000

Vergütung

Mr. Jiaquan Sun has been General Manager at Jiangsu Nhwa Pharmaceutical Co., Ltd. since May 31, 2013 and has been its Non-Independent Director since April 1, 2019. Mr. Sun serves as General Manager of Jian...

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Jiaquan Sun	GM & Non-Independent Director	11.3yrs	CN¥4.80m	0.070% CN¥ 17.8m
Gangsheng Li	Chief Financial Officer	1.9yrs	CN¥633.60k	keine Daten
Qing Fu	Deputy GM & Non-Independent Director	11.3yrs	CN¥200.00k	3.93% CN¥ 998.2m
Zengliang Chen	Deputy GM & Non-Independent Director	11.3yrs	CN¥200.00k	3.93% CN¥ 998.2m
Ziliang Yang	Deputy GM & Non-Independent Director	11.3yrs	CN¥200.00k	3.69% CN¥ 938.3m
Bao Zhou Duan	Deputy GM & Secretary	11.3yrs	CN¥413.70k	0.0053% CN¥ 1.3m

11.3yrs

Durchschnittliche Betriebszugehörigkeit

59yo

Durchschnittliches Alter

Erfahrenes Management: 002262Das Führungsteam des Unternehmens verfügt über eine langjährige Erfahrung (11.1 ).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Jiaquan Sun	GM & Non-Independent Director	14.3yrs	CN¥4.80m	0.070% CN¥ 17.8m
Qing Fu	Deputy GM & Non-Independent Director	17.4yrs	CN¥200.00k	3.93% CN¥ 998.2m
Zengliang Chen	Deputy GM & Non-Independent Director	17.4yrs	CN¥200.00k	3.93% CN¥ 998.2m
Ziliang Yang	Deputy GM & Non-Independent Director	17.4yrs	CN¥200.00k	3.69% CN¥ 938.3m
Pengsheng Sun	Non-Independent Chairman of the Board	17.4yrs	CN¥250.00k	4.87% CN¥ 1.2b
Guangji Wang	Independent Director	5.5yrs	CN¥50.00k	keine Daten
Yu Lan Li	Independent Director	2.4yrs	CN¥50.00k	keine Daten
Fengshou Wang	Chairman of the Supervisory Board	17.4yrs	keine Daten	keine Daten
Xinglei Jia	Member of the Supervisory Board	17.4yrs	keine Daten	keine Daten
Xiao Chen Qian	Employee Representative Member of Supervisory Board	17.4yrs	keine Daten	keine Daten
Xiaoxing Yin	Independent Director	2.4yrs	CN¥50.00k	keine Daten
Guoxiang Chen	Independent Director	2.4yrs	CN¥50.00k	keine Daten

17.4yrs

Durchschnittliche Betriebszugehörigkeit

61yo

Durchschnittliches Alter

Erfahrener Vorstand: 002262Die Vorstandsmitglieder sind sehr erfahren ( 17.2 ).

Jiangsu Nhwa Pharmaceutical Management

Management Kriterienprüfungen 3/4

Wichtige Informationen

Jüngste Management Updates

Jiangsu Nhwa Pharmaceutical Co., LTD, Annual General Meeting, Apr 24, 2024

High number of new directors

Jiangsu Nhwa Pharmaceutical Co., LTD Approves the Election of Chen Guoxiang and Li Yulan as Independent Directors

Insufficient new directors

Insufficient new directors

Jiangsu Nhwa Pharmaceutical Co., LTD, Annual General Meeting, Apr 29, 2022

Recent updates

Now 20% undervalued

Second quarter 2024 earnings released: EPS: CN¥0.36 (vs CN¥0.31 in 2Q 2023)

Jiangsu Nhwa Pharmaceutical Co., LTD to Report First Half, 2024 Results on Jul 31, 2024

Now 21% overvalued

Full year 2023 earnings released: EPS: CN¥1.03 (vs CN¥0.89 in FY 2022)

Jiangsu Nhwa Pharmaceutical Co., LTD, Annual General Meeting, Apr 24, 2024

Investor sentiment deteriorates as stock falls 17%

Jiangsu Nhwa Pharmaceutical Co., LTD to Report Fiscal Year 2023 Results on Mar 30, 2024

Third quarter 2023 earnings released: EPS: CN¥0.34 (vs CN¥0.30 in 3Q 2022)

New minor risk - Share price stability

Second quarter 2023 earnings released: EPS: CN¥0.31 (vs CN¥0.25 in 2Q 2022)

Jiangsu Nhwa Pharmaceutical Co., LTD to Report First Half, 2023 Results on Jul 31, 2023

Jiangsu Nhwa Pharmaceutical Co., Ltd. Receives Formal Approval from the National Medical Products Administration for OLINVYK

Full year 2022 earnings released: EPS: CN¥0.89 (vs CN¥0.79 in FY 2021)

Third quarter 2022 earnings released: EPS: CN¥0.30 (vs CN¥0.26 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.25 (vs CN¥0.24 in 2Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.25 (vs CN¥0.24 in 2Q 2021)

High number of new directors

Jiangsu Nhwa Pharmaceutical Co., LTD Approves the Election of Chen Guoxiang and Li Yulan as Independent Directors

First quarter 2022 earnings released: EPS: CN¥0.19 (vs CN¥0.17 in 1Q 2021)

Insufficient new directors

Insufficient new directors

Full year 2021 earnings released: EPS: CN¥0.79 (vs CN¥0.72 in FY 2020)

Jiangsu Nhwa Pharmaceutical Co., LTD, Annual General Meeting, Apr 29, 2022

Jiangsu Nhwa Pharmaceutical Co., LTD, Annual General Meeting, Apr 29, 2022

Jiangsu Nhwa Pharmaceutical Co., Ltd Proposes Cash Dividend for 2021

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Third quarter 2021 earnings released: EPS CN¥0.26 (vs CN¥0.21 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.24 (vs CN¥0.21 in 2Q 2020)

Jiangsu Nhwa Pharmaceutical Co., Ltd Announces 2020 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 02 June 2021

First quarter 2021 earnings released: EPS CN¥0.17 (vs CN¥0.14 in 1Q 2020)

New 90-day low: CN¥13.53

Full year 2020 earnings released: EPS CN¥0.72 (vs CN¥0.66 in FY 2019)

Revenue beats expectations

New 90-day low: CN¥14.10

Investor sentiment deteriorated over the past week

Jiangsu Nhwa Pharmaceutical Co., LTD to Report Fiscal Year 2020 Results on Mar 12, 2021

New 90-day low: CN¥15.46

New 90-day high: CN¥18.50

Third quarter earnings released

Third-quarter earnings released: Revenue misses expectations

Jiangsu Nhwa Pharmaceutical Co., LTD to Report Q3, 2020 Results on Oct 26, 2020

New 90-day low: CN¥15.34

New 90-day low - CN¥15.61

New 90-day high - CN¥18.57

Jiangsu Nhwa Pharmaceutical Co., LTD to Report First Half, 2020 Results on Jul 31, 2020

Geschäftsführer

Amtszeit

Vergütung

Führungsteam

Durchschnittliche Betriebszugehörigkeit

Durchschnittliches Alter

Vorstandsmitglieder

Durchschnittliche Betriebszugehörigkeit

Durchschnittliches Alter